Press Release

Invivoscribe Submits LeukoStrat® CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *